BERIPLEX AU human prothrombin complex 500 IU powder for injection vial, CSL Behring Australia Pty Ltd, CON-1251

The products will not comply with: - the requirement of indefinite geographical deferral for variant Creutzfeldt-Jakob disease (vCJD) risk, applicable to blood and plasma donors having spent a cumulative length of time of 6 months or more in the UK between 1980 and 1996 or receiving a transfusion or injection of blood or blood components while in the UK at any time on or after 1 January 1980. - Donor selection criteria for deferral following body piercing - where single-use equipment is used, and it is less than 4 months since the procedure and where the person tests negative for HCV using NAT - Donor selection criteria for deferral following tattoo - in that people who have a tattoo performed at a licensed/registered tattoo parlour or cosmetic clinic in Australia can be accepted as a donor for plasma for fractionation only with no deferral period from the time of the last tattoo procedure.